Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 9/20 | 0.63 |
| ▸ | USP2 | O75604 | 2/20 | 0.63 |
| ▸ | CCR8 | P51685 | 8/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.58 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5779430 | 0.95 | CYP2D6 (0.57) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5400231 | 0.91 | CYP2D6 (0.66) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5398775 | 0.89 | CYP2D6 (0.59) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5399223 | 0.89 | CYP2D6 (0.64) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5394015 | 0.89 | CYP2D6 (0.68) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5401887 | 0.88 | CYP2D6 (0.67) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5392159 | 0.88 | CYP2D6 (0.67) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5398898 | 0.88 | CYP2D6 (0.67) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5402786 | 0.87 | CCR8 (0.75) | CYP2D6USP2CCR8KCNH2CYP3A4 | |
| SCHEMBL5390511 | 0.86 | CYP2D6 (0.84) | CYP2D6USP2CCR8KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007509141-A | — | — | 2007-04-12 | — | — | JP | claimed |
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | claimed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | claimed |
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |